ACCUiN Next Generation Fusion Gene Analysis Panel

ALK, FGFR1, FGFR2, FGFR3, MET, NTRK1, NTRK2, NTRK3, RET, and ROS1 gene fusions

ACCUiN Next Generation Fusion Gene Analysis Panel
Next-Generation Genetic Testing

ACCUiN Next Generation Fusion Gene Analysis Panel

Product Code: CGF-48A, CGF-48B, CGF-48C, CGF-48D

Product Introduction

ACCUiN Next Generation Fusion Gene Analysis Panel is a qualitative detection designed using reverse transcription and Multiplex polymerase chain reaction (Multiplex PCR), requiring next-generation sequencing system (NGS) to detect whether test samples have specific gene fusion variants. ACCUiN Next Generation Fusion Gene Analysis Panel can be used to detect fusion variants in malignant solid tumor tissues with ALK (NM_004304), FGFR1 (NM_023110), FGFR2 (NM_022970), FGFR3 (NM_000142), MET (NM_001127500), NTRK1 (NM_002529), NTRK2 (NM_006180), NTRK3 (NM_002530), RET (NM_020975), and ROS1 (NM_002944). ACCUiN Next Generation Fusion Gene Analysis Panel has passed quality validation and functional verification to ensure performance stability and reproducibility. ACCUiN Next Generation Fusion Gene Analysis Panel can provide at least 48 detection reactions.

Specifications

  • CGF-48A: Index 1-24
  • CGF-48B: Index 25-48
  • CGF-48C: Index 49-72
  • CGF-48D: Index 73-96
  • Reaction quantity: 48 reactions
  • Detection target: ALK, FGFR1, FGFR2, FGFR3, MET, NTRK1, NTRK2, NTRK3, RET, ROS1 gene fusions
  • Detection method: Multiplex PCR + NGS
  • Sample type: Malignant solid tumor tissue

Simple Flowchart

ACCUiN Next Generation Fusion Gene Analysis Panel Flowchart
ACCUiN Biotech

Focusing on genomics, oncology, and infectious disease fields, dedicated to developing high-quality testing kits and automated analysis software.

Precision Testing, Ensuring Health

© 2025 ACCUiN Biotech Co., Ltd. All rights reserved.